Sophie Parmentier Batteur

Company: Biogen
Job title: VP, head of Neuromuscular Diseases Research Unit
Seminars:
Panel Discussion: Evaluating Current Strategies for ALS Target Identification: What are the Avenues to Still Prioritise? 11:15 am
• Outlining current avenues of disease pathology to identify and validate targets for familial and sporadic ALS • Processing disease pathology information to validate genetic ALS targets • Where are the current innovations for novel target identification?Read more
day: Day One AM